Odin (ANKS1A) Modulates EGF Receptor Recycling and Stability

The ANKS1A gene product, also known as Odin, was first identified as a tyrosine-phosphorylated component of the epidermal growth factor receptor network. Here we show that Odin functions as an effector of EGFR recycling. In EGF-stimulated HEK293 cells tyrosine phosphorylation of Odin was induced prior to EGFR internalization and independent of EGFR-to-ERK signaling. Over-expression of Odin increased EGF-induced EGFR trafficking to recycling endosomes and recycling back to the cell surface, and decreased trafficking to lysosomes and degradation. Conversely, Odin knockdown in both HEK293 and the non-small cell lung carcinoma line RVH6849, which expresses roughly 10-fold more EGF receptors than HEK293, caused decreased EGFR recycling and accelerated trafficking to the lysosome and degradation. By governing the endocytic fate of internalized receptors, Odin may provide a layer of regulation that enables cells to contend with receptor cell densities and ligand concentration gradients that are physiologically and pathologically highly variable.

[1]  Hongying Shen,et al.  Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane , 2012, Proceedings of the National Academy of Sciences.

[2]  M. Pellecchia,et al.  Solution structure of the first Sam domain of Odin and binding studies with the EphA2 receptor. , 2012, Biochemistry.

[3]  H. Kajiho,et al.  RINL, Guanine Nucleotide Exchange Factor Rab5-Subfamily, Is Involved in the EphA8-Degradation Pathway with Odin , 2012, PloS one.

[4]  Martin Kircher,et al.  Deep proteome and transcriptome mapping of a human cancer cell line , 2011, Molecular systems biology.

[5]  J. Ellenberg,et al.  The quantitative proteome of a human cell line , 2011, Molecular systems biology.

[6]  R. Cole,et al.  The interactome of a PTB domain-containing adapter protein, Odin, revealed by SILAC. , 2011, Journal of proteomics.

[7]  Susan E Abbatiello,et al.  Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry. , 2010, Analytical chemistry.

[8]  Florian Gnad,et al.  PHOSIDA 2011: the posttranslational modification database , 2010, Nucleic Acids Res..

[9]  C. Guérin,et al.  Colocalization Analysis in Fluorescence Micrographs: Verification of a More Accurate Calculation of Pearson's Correlation Coefficient , 2010, Microscopy and Microanalysis.

[10]  M. Hung,et al.  Nuclear trafficking of the epidermal growth factor receptor family membrane proteins , 2010, Oncogene.

[11]  Masaru Tomita,et al.  Towards the systematic discovery of signal transduction networks using phosphorylation dynamics data , 2010, BMC Bioinformatics.

[12]  Brendan MacLean,et al.  Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .

[13]  Jieun A. Kim,et al.  The SAM Domains of Anks Family Proteins Are Critically Involved in Modulating the Degradation of EphA Receptors , 2010, Molecular and Cellular Biology.

[14]  I. Madshus,et al.  Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking , 2009, Journal of Cell Science.

[15]  V. Grantcharova,et al.  Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis , 2009, Science Signaling.

[16]  M. Moran,et al.  Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041* , 2009, Molecular & Cellular Proteomics.

[17]  Mads Lerdrup,et al.  Differential Effects of EGFR Ligands on Endocytic Sorting of the Receptor , 2009, Traffic.

[18]  L. Luttrell,et al.  Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor. , 2009, Biochemistry.

[19]  P. Woodman.  ESCRT proteins, endosome organization and mitogenic receptor down-regulation. , 2009, Biochemical Society transactions.

[20]  Gordon B. Mills,et al.  Derailed endocytosis: an emerging feature of cancer , 2008, Nature Reviews Cancer.

[21]  S. Feller,et al.  Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells , 2008, Cell Communication and Signaling.

[22]  I. Madshus,et al.  Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis , 2008, Journal of cellular and molecular medicine.

[23]  K. Roepstorff,et al.  Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer , 2008, Histochemistry and Cell Biology.

[24]  M. Moran,et al.  Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. , 2008, Journal of proteome research.

[25]  Jongdae Shin,et al.  Identification of Phosphotyrosine Binding Domain-Containing Proteins as Novel Downstream Targets of the EphA8 Signaling Function , 2007, Molecular and Cellular Biology.

[26]  Blagoy Blagoev,et al.  Quantitative proteomic assessment of very early cellular signaling events , 2007, Nature Biotechnology.

[27]  Hiroaki Sakurai,et al.  Transient Suppression of Ligand-mediated Activation of Epidermal Growth Factor Receptor by Tumor Necrosis Factor-α through the TAK1-p38 Signaling Pathway* , 2007, Journal of Biological Chemistry.

[28]  D. Lauffenburger,et al.  Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks , 2007, Proceedings of the National Academy of Sciences.

[29]  E. Kornilova,et al.  Epidermal growth factor (EGF) receptor endocytosis is accompanied by reorganization of microtubule system in HeLa cells , 2007, Cell biology international.

[30]  Daniel A. Haber,et al.  Epidermal growth factor receptor mutations in lung cancer , 2007, Nature Reviews Cancer.

[31]  S. Winograd-Katz,et al.  Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of the EGF receptor , 2006, Oncogene.

[32]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[33]  Y. Yarden,et al.  p38 MAP kinase mediates stress‐induced internalization of EGFR: implications for cancer chemotherapy , 2006, The EMBO journal.

[34]  E. Petricoin,et al.  Dynamic Profiling of the Post-translational Modifications and Interaction Partners of Epidermal Growth Factor Receptor Signaling after Stimulation by Epidermal Growth Factor Using Extended Range Proteomic Analysis (ERPA)*S , 2006, Molecular & Cellular Proteomics.

[35]  Angelo Paradiso,et al.  The complexity of targeting EGFR signalling in cancer: from expression to turnover. , 2006, Biochimica et biophysica acta.

[36]  Gavin MacBeath,et al.  A quantitative protein interaction network for the ErbB receptors using protein microarrays , 2006, Nature.

[37]  G. Cavet,et al.  Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients , 2005, Clinical Cancer Research.

[38]  E. Brown,et al.  Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. , 2005, Cancer research.

[39]  D. Lauffenburger,et al.  Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules*S , 2005, Molecular & Cellular Proteomics.

[40]  A. Sorkin,et al.  Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis. , 2005, Molecular biology of the cell.

[41]  I. Lax,et al.  The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway , 2004, BMC Biology.

[42]  Troels Z. Kristiansen,et al.  Mouse embryonic fibroblasts derived from Odin deficient mice display a hyperproliiferative phenotype. , 2004, DNA research : an international journal for rapid publication of reports on genes and genomes.

[43]  M. Mann,et al.  Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics , 2004, Nature Biotechnology.

[44]  M. Moran,et al.  Differential phosphoprofiles of EGF and EGFR kinase inhibitor-treated human tumor cells and mouse xenografts , 2004, Clinical Proteomics.

[45]  Tony Pawson,et al.  Specificity in Signal Transduction From Phosphotyrosine-SH2 Domain Interactions to Complex Cellular Systems , 2004, Cell.

[46]  D. Teis,et al.  The odd couple: signal transduction and endocytosis , 2003, Cellular and Molecular Life Sciences CMLS.

[47]  Troels Z. Kristiansen,et al.  Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases , 2002, Oncogene.

[48]  Joseph Schlessinger,et al.  Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor , 2002, Cell.

[49]  L. E. Johannessen,et al.  Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies , 2002, The Journal of cell biology.

[50]  Y. Yarden,et al.  A mutant EGF‐receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling , 2002, The EMBO journal.

[51]  Y. Yarden.  The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. , 2001, European journal of cancer.

[52]  M. Zerial,et al.  Rab11 regulates recycling through the pericentriolar recycling endosome , 1996, The Journal of cell biology.

[53]  M. Moran,et al.  Requirement for the Adapter Protein GRB2 in EGF Receptor Endocytosis , 1996, Science.

[54]  A. Sorkin,et al.  Epidermal Growth Factor Receptor Interaction with Clathrin Adaptors Is Mediated by the Tyr974-containing Internalization Motif* , 1996, The Journal of Biological Chemistry.

[55]  A. Ullrich,et al.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.

[56]  H. Sussman,et al.  Complete inhibition of transferrin recycling by monensin in K562 cells. , 1984, The Journal of biological chemistry.

[57]  I. Pastan,et al.  The morphologic pathway of binding and internalization of epidermal growth factor in cultured cells. Studies on A431, KB, and 3T3 cells, using multiple methods of labelling. , 1983, Experimental cell research.

[58]  A. Sorkin,et al.  Endocytosis and intracellular trafficking of ErbBs. , 2008, Experimental cell research.

[59]  M. Krainer,et al.  Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways. , 2007, The international journal of biochemistry & cell biology.